Welcome Matthew Ishahak, Rita Levi-Montalcini Postdoctoral Fellow

On June 1 the CRM welcomed its first Rita Levi-Montalcini Postdoctoral Fellow, Matthew Ishahak. Matthew completed his PhD at the University of Miami, and is joining the lab of CRM member Jeffrey Millman, where he will use his expertise in microfluidics to study stem cell-derived beta cell therapies for diabetes. Welcome, Matthew!

New protocol leads to better stem cell-derived pancreatic B-cells (Links to an external site)

Researchers in the Millman Lab have improved upon their previous protocol to generate pancreatic beta cells from human stem cells that more closely resemble authentic beta cells. Ultimately, scientists, like Millman, hope to use these cells as a cellular transplant to cure diabetes. Velazco-Cruz L, Song J, Maxwell KG, Goedegebuure MM, Augsornworawat P, Hogrebe NJ, […]

Jeffrey Millman awarded US patent for stem-cell derived B-cells (Links to an external site)

Center of Regenerative Medicine faculty member, Dr. Jeffrey Millman, was awarded a US patent for methods to derive pancreatic B-cells from pluripotent stem cells. Millman, who is an Assistant Professor in the Division of Endocrinology, was involved in this work while a postdoc with Douglas Melton at Harvard University, and it continues to be the […]